Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Martín Estrada-Valencia, Clara Herrera-Arozamena, Concepción Pérez, Dolores Viña, José A. Morales-García, Ana Pérez-Castillo, Eva Ramos, Alejandro Romero, Erik Laurini, Sabrina Pricl & María Isabel Rodríguez-Franco. (2019) New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 712-727.
Read now
Read now
Articles from other publishers (70)
Y.A. Zorkina, I.O. Morozova, O.V. Abramova, A.G. Ochneva, O.A. Gankina, A.V. Andryushenko, M.V. Kurmyshev, G.P. Kostyuk & A.Yu. Morozova. (2024) Use of modern classification systems for complex diagnostics of Alzheimer’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 124:1, pages 121.
Crossref
Crossref
Travis A K Bannell & Joseph J B Cockburn. (2023) The molecular structure and function of fibrocystin, the key gene product implicated in autosomal recessive polycystic kidney disease (ARPKD). Annals of Human Genetics 88:1, pages 58-75.
Crossref
Crossref
Jigar Vyas, Nensi Raytthatha & Bhupendra Gopalbhai Prajapati. 2024. Alzheimer's Disease and Advanced Drug Delivery Strategies. Alzheimer's Disease and Advanced Drug Delivery Strategies
73
92
.
Umang Shah, Aneri Shah, Sandip Patel, Alkesh Patel, Mehul Patel, Nilay Solanki, Swayamprakash Patel, Ashish Patel, Veena Patel & Bhavesh Patel. (2023) Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration
of Cognitive Function in Midlife as well as its Treatment. CNS & Neurological Disorders - Drug Targets 22:10, pages 1462-1471.
Crossref
Crossref
Unnati Jain, Surabhi Johari & Priyanka Srivastava. (2023) Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer’s Disease. Molecular Neurobiology.
Crossref
Crossref
Nidhi Puranik, Dhananjay Yadav & Minseok Song. (2023) Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective. International Journal of Molecular Sciences 24:18, pages 14044.
Crossref
Crossref
Ali Abdulmawjood Mohammed, Sagar S. Barale, Subodh Ashok Kamble, Sneha B. Paymal & Kailas D. Sonawane. (2023) Molecular insights into the inhibition of early stages of Aβ peptide aggregation and destabilization of Alzheimer's Aβ protofibril by dipeptide D-Trp-Aib: A molecular modelling approach. International Journal of Biological Macromolecules 242, pages 124880.
Crossref
Crossref
Kakarla Ramakrishna, Lakshmi Vineela Nalla, Dumala Naresh, Kojja Venkateswarlu, Matte Kasi Viswanadh, Buchi N. Nalluri, Guntupalli Chakravarthy, Sajusha Duguluri, Payal Singh, Sachchida Nand Rai, Ashish Kumar, Veer Singh & Santosh Kumar Singh. (2023) WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective. Diseases 11:3, pages 89.
Crossref
Crossref
Firoz Anwar, Fahad A Al-Abbasi, Salma Naqvi, Ryan Adnan Sheikh, Sultan Alhayyani, Amer H Asseri, Turky Omar Asar & Vikas Kumar. (2023) Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma. International Journal of Nanomedicine Volume 18, pages 2737-2756.
Crossref
Crossref
Cem Yamali & Seyda Donmez. (2023) Recent Developments in Tacrine-based Hybrids as a Therapeutic Option
for Alzheimer’s Disease. Mini-Reviews in Medicinal Chemistry 23:7, pages 869-880.
Crossref
Crossref
Paulo Cézar Prado, Josélia Alencar Lima, Lidilhone Hamerski & Magdalena Nascimento Rennó. (2023) Natural Products with BACE1 and GSK3β Inhibitory Activity. Mini-Reviews in Medicinal Chemistry 23:7, pages 881-895.
Crossref
Crossref
Bartosz Twarowski & Mariola Herbet. (2023) Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review. International Journal of Molecular Sciences 24:7, pages 6518.
Crossref
Crossref
Marie Tautou, Florian Descamps, Paul-Emmanuel Larchanché, Luc Buée, Jamal El Bakali, Patricia Melnyk & Nicolas Sergeant. (2023) A Polyaminobiaryl-Based β-secretase Modulator Alleviates Cognitive Impairments, Amyloid Load, Astrogliosis, and Neuroinflammation in APPSwe/PSEN1ΔE9 Mice Model of Amyloid Pathology. International Journal of Molecular Sciences 24:6, pages 5285.
Crossref
Crossref
Baljit Kaur, Vivesh & Palwinder Singh. (2023) Alzheimer’s Disease: Treatment of Multi-Factorial Disorders with Multi-
Target Approach. Mini-Reviews in Medicinal Chemistry 23:4, pages 380-398.
Crossref
Crossref
Jacqueline M. Garrick, Toby B. Cole, Khoi Dao, Ashley Phillips & Lucio G. Costa. (2023) Perinatal diesel exhaust exposure causes persistent changes in the brains of aged mice: An assessment of behavioral and biochemical endpoints related to neurodegenerative disease. Environmental Toxicology 38:4, pages 899-913.
Crossref
Crossref
Anna Mathew, Vignesh Balaji E, Sreedhara Ranganath K. Pai, Anoop Kishore, Vasudev Pai, Ramadevi Pemmireddy & Chandrashekar K.S. (2023) Current Drug Targets in Alzheimer’s Associated Memory Impairment: A
Comprehensive Review. CNS & Neurological Disorders - Drug Targets 22:2, pages 255-275.
Crossref
Crossref
Pooja Nadholta, Swati Kumari Choudhary & Manjari Rain. 2023. Ayurvedic Herbal Preparations in Neurological Disorders. Ayurvedic Herbal Preparations in Neurological Disorders
587
610
.
José-Luis Velasco-Bolom & Laura Domínguez. (2022) Mechanistic regulation of γ-secretase by their substrates. Physical Chemistry Chemical Physics 24:32, pages 19223-19232.
Crossref
Crossref
Yara Mashal, Hosam Abdelhady & Arun K. Iyer. (2022) Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease. Biomolecules 12:7, pages 1001.
Crossref
Crossref
Som Singh, Felix Yang, Andy Sivils, Victoria Cegielski & Xiang-Ping Chu. (2022) Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease. Biomolecules 12:7, pages 996.
Crossref
Crossref
Vladimir Volloch & Sophia Rits-Volloch. (2022) The Amyloid Cascade Hypothesis 2.0: On the Possibility of Once-in-a-Lifetime-Only Treatment for Prevention of Alzheimer’s Disease and for Its Potential Cure at Symptomatic Stages. Journal of Alzheimer's Disease Reports 6:1, pages 369-399.
Crossref
Crossref
Sandeep Kumar Singh, Vyshnavy Balendra, Ahmad A Obaid, Josephine Esposto, Maria A Tikhonova, Naveen Kumar Gautam & Burkhard Poeggeler. (2022) Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease. Metallomics 14:6.
Crossref
Crossref
Kate L. Jordan, David J. Koss, Tiago F. Outeiro & Flaviano Giorgini. (2022) Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease. Biomedicines 10:5, pages 1141.
Crossref
Crossref
Xianhai Huang & Robert Aslanian. 2022. Contemporary Accounts in Drug Discovery and Development. Contemporary Accounts in Drug Discovery and Development
51
83
.
José J. M. Vitória, Diogo Trigo & Odete A. B. da Cruz e Silva. (2022) Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing. Cellular and Molecular Life Sciences 79:2.
Crossref
Crossref
AlejandroR Roda, Gabriel Serra-Mir, Laia Montoliu-Gaya, Lidia Tiessler & Sandra Villegas. (2022) Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease. Neural Regeneration Research 17:8, pages 1666.
Crossref
Crossref
Bani Bandana Ganguly. 2022. Genetics and Neurobiology of Down Syndrome. Genetics and Neurobiology of Down Syndrome
321
367
.
Swaroop Thonda, Srinivas N. Puttapaka, Swathi V. Kona & Shasi V. Kalivendi. (2021) Extracellular-Signal-Regulated Kinase Inhibition Switches APP Processing from β- to α-Secretase under Oxidative Stress: Modulation of ADAM10 by SIRT1/NF-κB Signaling. ACS Chemical Neuroscience 12:21, pages 4175-4186.
Crossref
Crossref
Elnaz Nourollahimoghadam, Shaghayegh Gorji, Ali Gorji & Maryam Khaleghi Ghadiri. (2021) Therapeutic role of yoga in neuropsychological disorders. World Journal of Psychiatry 11:10, pages 754-773.
Crossref
Crossref
Sanchari Mukhopadhyay & Debanjan Banerjee. (2021) A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease. Journal of Alzheimer's Disease 83:4, pages 1537-1552.
Crossref
Crossref
Joshua Santos, Mark Tristan Quimque, Rhenz Alfred Liman, Jay Carl Agbay, Allan Patrick G. Macabeo, Mary Jho-Anne Corpuz, Yun-Ming Wang, Tsai-Te Lu, Chia-Her Lin & Oliver B. Villaflores. (2021) Computational and Experimental Assessments of Magnolol as a Neuroprotective Agent and Utilization of UiO-66(Zr) as Its Drug Delivery System. ACS Omega 6:38, pages 24382-24396.
Crossref
Crossref
Jorge Ibañez-Vega, Constanza Vilchez, Karin Jimenez, Carlos Guevara, Paula I. Burgos & Rodrigo Naves. (2021) Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases. Journal of Autoimmunity 123, pages 102702.
Crossref
Crossref
Aaron T. BalanaMatthew R. Pratt. (2021)
Mechanistic roles for altered
O
-GlcNAcylation in neurodegenerative disorders
. Biochemical Journal 478:14, pages 2733-2758.
Crossref
Crossref
Radhika Vadakkini Nair, Parasuraman Padmanabhan, Balázs Gulyás & Murukeshan Vadakke Matham. (2021) Fluorescence Resonance Energy Transfer (FRET)-Based ThT Free Sensing of Beta-Amyloid Fibrillation by Carbon Dot-Ag Composites. Plasmonics 16:3, pages 863-872.
Crossref
Crossref
Sarah Lye, Caitlin E. Aust, Lyn R. Griffiths & Francesca Fernandez. (2021) Exploring new avenues for modifying course of progression of Alzheimer's disease: The rise of natural medicine. Journal of the Neurological Sciences 422, pages 117332.
Crossref
Crossref
Samuel King & Cenk Suphioglu. 2020. Neuroprotection - New Approaches and Prospects. Neuroprotection - New Approaches and Prospects.
Juliana González-Sanmiguel, Christina M. A. P. Schuh, Carola Muñoz-Montesino, Pamina Contreras-Kallens, Luis G. Aguayo & Sebastian Aguayo. (2020) Complex Interaction between Resident Microbiota and Misfolded Proteins: Role in Neuroinflammation and Neurodegeneration. Cells 9:11, pages 2476.
Crossref
Crossref
Mei Tong He, Ji-Hyun Kim, Ji Hyun Kim, Chan Hum Park & Eun Ju Cho. (2020) Combination of Carthamus tinctorius L. seed and Taraxacum coreanum exerts synergistic effects on learning and memory function by regulating metabolism of amyloid beta in mice. Journal of Functional Foods 72, pages 104048.
Crossref
Crossref
Md. Sahab Uddin, Md. Tanvir Kabir, Md. Sohanur Rahman, Tapan Behl, Philippe Jeandet, Ghulam Md Ashraf, Agnieszka Najda, May N. Bin-Jumah, Hesham R. El-Seedi & Mohamed M. Abdel-Daim. (2020) Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease. International Journal of Molecular Sciences 21:16, pages 5858.
Crossref
Crossref
Archana S. Gurjar, Vivek S. Solanki, Ankita R. Meshram & Suchita S. Vishwakarma. (2019) Exploring beta amyloid cleavage enzyme‐1 inhibition and neuroprotective role of benzimidazole analogues as anti‐alzheimer agents. Journal of the Chinese Chemical Society 67:5, pages 864-873.
Crossref
Crossref
Wioletta Rozpędek-Kamińska, Natalia Siwecka, Adam Wawrzynkiewicz, Radosław Wojtczak, Dariusz Pytel, J. Alan Diehl & Ireneusz Majsterek. (2020) The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases. International Journal of Molecular Sciences 21:6, pages 2108.
Crossref
Crossref
Stefano Muscat, Lorenzo Pallante, Filip Stojceski, Andrea Danani, Gianvito Grasso & Marco Agostino Deriu. (2020) The Impact of Natural Compounds on S-Shaped Aβ42 Fibril: From Molecular Docking to Biophysical Characterization. International Journal of Molecular Sciences 21:6, pages 2017.
Crossref
Crossref
Syed S. Ahmad, Shahzad Khan, Mohammad A. Kamal & Umam Wasi. (2020) The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer’s Disease: A Review. CNS & Neurological Disorders - Drug Targets 18:9, pages 657-667.
Crossref
Crossref
Gianvito Grasso & Andrea Danani. (2020) Molecular simulations of amyloid beta assemblies. Advances in Physics: X 5:1, pages 1770627.
Crossref
Crossref
Zhidong Xu, Caihong Miao, Fugui Dong, Limeng Jia, Wei Li, Min Wang, Wenqing Liu & Qi-Huang Zheng. (2020) Radiosynthesis of a carbon-11 labeled tetrahydrobenzisoxazole derivative as a new PET probe for γ-secretase imaging in Alzheimer's disease. Applied Radiation and Isotopes 155, pages 108915.
Crossref
Crossref
Chungwen Liang, Sergey N. Savinov, Jasna Fejzo, Stephen J. Eyles & Jianhan Chen. (2019) Modulation of Amyloid-β42 Conformation by Small Molecules Through Nonspecific Binding. Journal of Chemical Theory and Computation 15:10, pages 5169-5174.
Crossref
Crossref
Md. Sahab Uddin & Md. Tanvir Kabir. (2019) Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest. Frontiers in Cell and Developmental Biology 7.
Crossref
Crossref
Miriama Simunkova, Saleh H. Alwasel, Ibrahim M. Alhazza, Klaudia Jomova, Vojtech Kollar, Miroslav Rusko & Marian Valko. (2019) Management of oxidative stress and other pathologies in Alzheimer’s disease. Archives of Toxicology 93:9, pages 2491-2513.
Crossref
Crossref
Sudhir M. Hiremath, Anil S. Patil, Chidanandayya S. Hiremath, Mahantesha Basangouda, Seema S. Khemalapure, Ninganagouda R. Patil, Shivaraj B. Radder, Sanja J. Armaković & Stevan Armaković. (2019) Structural, spectroscopic characterization of 2-(5-methyl-1-benzofuran-3-yl) acetic acid in monomer, dimer and identification of specific reactive, drug likeness properties: Experimental and computational study. Journal of Molecular Structure 1178, pages 1-17.
Crossref
Crossref
Jahangir Alam & Lalit Sharma. (2019) Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review. Current Drug Targets 20:3, pages 316-339.
Crossref
Crossref
Patrick A. Lewis & Jennifer E. Spillane. 2019. The Molecular and Clinical Pathology of Neurodegenerative Disease. The Molecular and Clinical Pathology of Neurodegenerative Disease
25
82
.
Florent Alix, Vincent Gembus, Laurent Coquet, Marie Hubert-Roux, Philippe Chan, Lina Truong, Muriel Sebban, Gaël Coadou, Hassan Oulyadi, Cyril Papamicaël & Vincent Levacher. (2018) Dihydroquinoline Carbamate DQS1-02 as a Prodrug of a Potent Acetylcholinesterase Inhibitor for Alzheimer’s Disease Therapy: Multigram-Scale Synthesis, Mechanism Investigations, in Vitro Safety Pharmacology, and Preliminary in Vivo Toxicology Profile. ACS Omega 3:12, pages 18387-18397.
Crossref
Crossref
Haifang Wang, Shuhui Ma, Jing Li, Miaomiao Zhao, Xueping Huo, Jingying Sun, Lijun Sun, Jun Hu & Qinshe Liu. (2018) ADAM17 participates in the protective effect of paeoniflorin on mouse brain microvascular endothelial cells. Journal of Cellular Physiology 233:12, pages 9320-9329.
Crossref
Crossref
Xin Wang & Gang Pei. (2018) Visualization of Alzheimer’s Disease Related α-/β-/γ-Secretase Ternary Complex by Bimolecular Fluorescence Complementation Based Fluorescence Resonance Energy Transfer. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Kazuya Fukuyama, Shota Kakio, Yosuke Nakazawa, Kenji Kobata, Megumi Funakoshi‐Tago, Toshiharu Suzuki & Hiroomi Tamura. (2018) Roasted Coffee Reduces β‐Amyloid Production by Increasing Proteasomal β‐Secretase Degradation in Human Neuroblastoma SH‐SY5Y Cells. Molecular Nutrition & Food Research 62:21.
Crossref
Crossref
Xin Wang, Congcong Wang & Gang Pei. (2018) α-secretase ADAM10 physically interacts with β-secretase BACE1 in neurons and regulates CHL1 proteolysis. Journal of Molecular Cell Biology 10:5, pages 411-422.
Crossref
Crossref
Anna L. Stern, Shivesh Ghura, Patrick J. Gannon, Cagla Akay-Espinoza, Jessica M. Phan, Alan C. Yee, Robert Vassar, Benjamin B. Gelman, Dennis L. Kolson & Kelly L. Jordan-Sciutto. (2018) BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism. The Journal of Neuroscience 38:18, pages 4288-4300.
Crossref
Crossref
Vorapin Chinchalongporn, Mayuri Shukla & Piyarat Govitrapong. (2018)
Melatonin ameliorates Aβ
42
‐induced alteration of β
APP
‐processing secretases via the melatonin receptor through the Pin1/
GSK
3β/
NF
‐κB pathway in
SH
‐
SY
5Y cells
. Journal of Pineal Research 64:4.
Crossref
Crossref
William G. RobichauxIIIIII & Xiaodong Cheng. (2018) Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development. Physiological Reviews 98:2, pages 919-1053.
Crossref
Crossref
Heyun Yang, Tingting Hou, Wei Wang, Yumin Luo, Feng Yan & Jianping Jia. (2018) The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer’s Disease (PS1V97L). Journal of Alzheimer's Disease 62:4, pages 1609-1621.
Crossref
Crossref
Juraj Velcicky, Ursula Bodendorf, Pascal Rigollier, Robert Epple, Daniel R. Beisner, Danilo Guerini, Philip Smith, Bo Liu, Roland Feifel, Peter Wipfli, Reiner Aichholz, Philippe Couttet, Ina Dix, Toni Widmer, Ben Wen & Trixi Brandl. (2018) Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. Journal of Medicinal Chemistry 61:3, pages 865-880.
Crossref
Crossref
Surbhi Sharma, Richard J. Young, Jingchun Chen, Xiangning Chen, Edwin C. Oh & Martin R. Schiller. (2018) Minimotifs dysfunction is pervasive in neurodegenerative disorders. Alzheimer's & Dementia: Translational Research & Clinical Interventions 4:1, pages 414-432.
Crossref
Crossref
Daniel Pedro CardinaliDaniel Pedro Cardinali. 2018. Autonomic Nervous System. Autonomic Nervous System
313
373
.
Nehru Sai Suresh Chalichem, Chaitanya Gonugunta, Praveen Thaggikuppe Krishnamurthy & Basavan Duraiswamy. (2017) DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review. American Journal of Alzheimer's Disease & Other Dementiasr 32:7, pages 444-451.
Crossref
Crossref
Shagufta H. Khan & Raj Kumar. (2017) Trehalose induced conformational changes in the amyloid-β peptide. Pathology - Research and Practice 213:6, pages 643-648.
Crossref
Crossref
Niccoló Parenti, Ambra Del Grosso, Claudia Antoni, Marco Cecchini, Renato Corradetti, Francesco S. Pavone & Martino Calamai. (2017) Direct imaging of APP proteolysis in living cells. PeerJ 5, pages e3086.
Crossref
Crossref
Francesca Lake. (2017)
Welcome to volume 3 of
Future Science OA
. Future Science OA 3:1, pages FSO156.
Crossref
Crossref
Tze Han Sum, Tze Jing Sum, Súil Collins, Warren R. J. D. Galloway, David G. Twigg, Florian Hollfelder & David R. Spring. (2017) Divergent synthesis of biflavonoids yields novel inhibitors of the aggregation of amyloid β (1–42). Organic & Biomolecular Chemistry 15:21, pages 4554-4570.
Crossref
Crossref
Martín Estrada, Concepción Pérez, Elena Soriano, Erik Laurini, Maurizio Romano, Sabrina Pricl, José A Morales-García, Ana Pérez-Castillo & María Isabel Rodríguez-Franco. (2016) New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition. Future Medicinal Chemistry 8:11, pages 1191-1207.
Crossref
Crossref
Francesca Lake. (2016)
Welcome to volume 2 of
Future Science OA
. Future Science OA 2:1.
Crossref
Crossref